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Sex differences in Tfh cell help 
to B cells contribute to sexual 
dimorphism in severity of rat 
collagen-induced arthritis
Mirjana Dimitrijević1, Nevena Arsenović-Ranin2, Duško Kosec3, Biljana Bufan2, 
Mirjana nacka-Aleksić4, Ivan pilipović3 & Gordana Leposavić4*
The study examined germinal centre (GC) reaction in lymph nodes draining inflamed joints and adjacent 
tissues (dLNs) in male and female Dark Agouti rat collagen type II (CII)-induced arthritis (CIA) model of 
rheumatoid arthritis. Female rats exhibiting the greater susceptibility to CIA mounted stronger serum 
CII-specific IgG response than their male counterparts. This correlated with the higher frequency of GC 
B cells in female compared with male dLNs. Consistently, the frequency of activated/proliferating Ki-
67+ cells among dLN B cells was higher in females than in males. This correlated with the shift in dLN 
T follicular regulatory (Tfr)/T follicular helper (Tfh) cell ratio towards Tfh cells in females, and greater 
densities of CD40L and CD40 on their dLN T and B cells, respectively. The higher Tfh cell frequency 
in females was consistent with the greater dLN expression of mRNA for IL-21/27, the key cytokines 
involved in Tfh cell generation and their help to B cells. Additionally, in CII-stimulated female rat dLN 
cell cultures IFN-γ/IL-4 production ratio was shifted towards IFN-γ. Consistently, the serum IgG2a(b)/
IgG1 CII-specific antibody ratio was shifted towards an IgG2a(b) response in females. Thus, targeting 
T-/B-cell interactions should be considered in putative further sex-based translational pharmacology 
research.
Rheumatoid arthritis (RA) is a chronic autoimmune systemic inflammatory disease characterized by synovial 
inflammation and the progressive destruction of joint cartilage and bones significantly reducing health-related 
quality of life1. The prevalence of RA is approximately threefold higher in women than in men, and the disease in 
women exhibits a more severe course2. Thus, research focused on sex as a determinant of disease severity could be 
important for further personalized management of patients with this autoimmune disease3.
Collagen-induced arthritis (CIA) is a well-established experimental model mimicking many aspects of RA 
immunopathogenesis4. Differently from most of the mouse models of experimentally induced arthritis5,6, in 
several studies, female rats exhibited greater susceptibility to CIA compared with their male counterparts7–10. 
Thus, these rat CIA models seem to be suitable for research aimed to elucidate cellular and molecular mecha-
nisms underlying sex differences in pathogenesis and clinical outcome of RA, as a base for designing efficient 
sex-specific therapies.
Sex differences in susceptibility to autoimmune diseases have been related to sex-based differences in 
immunopathogenesis and susceptibility of the target tissue to damage caused by autoimmune or inflammatory 
burden11,12. These differences most likely arise from intricate interactions between circulating sex steroids, micro-
biota, genetic and environmental factors11,13.
CIA is shown to be T helper (Th)1/Th17 mediated disease14. The main function of Th cells is to activate mac-
rophages and fibroblasts and transform them into tissue-destructive cells15. Our previous studies in Dark Agouti 
(DA) rat CIA model showed more robust Th1/17 responses in female rats (exhibiting the higher incidence and the 
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more severe CIA) compared with their male counterparts and pointed out to some underlying mechanisms9,10. 
However, although CD4+ T cells are of essential significance for the induction and maintenance of inflammation 
in CIA and RA, the activation of self-antigen-specific B cells is thought to be extremely important for the target 
tissue damage16. The role of B cells in the pathogenesis of CIA, as in RA, is likely to be complex17.
B cells contribute to RA development by producing antibodies specific for self-proteins, and/or altered 
self-proteins, such as collagen type II (CII), Fc portion of IgG (rheumatoid factor) and citrullinated protein 
antigens18. To corroborate the importance of antibodies in the pathogenesis of CIA are data indicating that the 
absence of B cells in genetically modified mice19 and lowered number of B cells in mice treated with anti-CD20 
antibodies20, inducing lack of CII-specific autoantibodies, protected mice against CIA19. The pathogenic role of 
B cells in CIA is mainly attributed to the secretion of anti-collagen antibodies17. The CII-specific autoantibodies 
are crucial for both the initiation and perpetuation of the clinical disease21. These antibodies activate complement 
and/or residential and infiltrated cells carrying Fcγ receptor (FcγR) in the synovia to produce inflammatory 
cytokines, mediators and enzymes damaging cartilage and bone21. The severity of tissue damage and inflamma-
tion is largely determined by the outcome of interactions between the autoantibodies and complement and/or 
FcγR bearing cells21. This interaction depends on the antibody class/subclass profile (as different IgG subclasses 
differ in their capacity to bind FcγR or to activate complement) and their titres, as well as on the abundance of 
FcγR bearing inflammatory cells at the site of immune complex deposition21. It is also noteworthy that in the 
rat IgG class switching mainly depends on IFN-γ/IL-4 production ratio22,23. However, IL-17 can also participate 
in this regulation, as IL-17-deficient mice upon immunization with collagen exhibited the impaired capacity of 
collagen-specific IgG2a antibody generation24.
Germinal centres (GCs) provide a proper microenvironment for activation, somatic diversification, and affin-
ity maturation of (auto)reactive B lymphocytes which occurred before the production of (auto)antibodies25. Mice 
that were selectively deficient in GCs are almost fully protected against CIA, whereas they are fully susceptible to 
collagen antibody-induced arthritis17. Following the induction of CIA GCs develop in inflamed joint tissues and 
secondary lymphoid tissues, including the lymph nodes draining inflamed joints and adjacent tissues (dLNs), 
often referred to as reactive lymph nodes26. An accumulating body of evidence suggests an important role of 
dLNs in the development and progression of CIA and RA trough cross-talk with the inflamed tissues, so periph-
eral tissues and their dLNs operate as a functional pathogenic unit26. Of note, Th cells from GCs referred to as 
follicular helper T (Tfh) cells critically contribute to the proliferation of (auto)antigen-primed GC B cells, isotype 
switching, and their somatic hypermutations leading to the generation of long-lived plasma cells and memory B 
cells27. Conventional CD4+ T cells differentiate into Tfh cells through a specific pathway that terminates in the 
high expression of the B-cell follicle homing chemokine (C-X-C motif) receptor 5 (CXCR5) and their localization 
to the GCs27,28. Thus, the stringent control of Tfh cell generation and function is critically important for the induc-
tion of an optimal humoral response against thymus-dependent antigens and the prevention of self-reactivity, 
alike29,30. Consistently, deregulations of Tfh response can contribute to the production of pathogenic autoantibod-
ies, and thereby the promotion of autoantibody-mediated autoimmune diseases, including RA29,30. To corroborate 
this notion, in CIA, T-cell-specific CXCR5 deficiency results in a significant reduction in the formation of GCs 
leading to the decreased levels of collagen-specific antibodies and the resistance to CIA induction25. On the other 
hand, a subset of CD4+ Foxp3+ regulatory T cells expressing Tfh cell-associated molecules, including CXCR5, 
termed T follicular regulatory (Tfr) cells plays a critical role in the controlling Tfh cell activity, and thereby indi-
rectly GC B-cell activity and the magnitude of (auto)antibody production27. However, Tfr cells may exhibit a 
direct regulatory action on GC B cells31,32. Thus, as Tfh and Tfr cells act as reciprocal and antagonistic regulators 
of B-cell responses, their balanced action is suggested to be essential for immune homeostasis29. Consistently, 
aberrant or disordered Tfh/Tfr cell balance may cause the loss of immune tolerance and consequently enhanced 
production of autoantibodies29,33,34.
To the best of our knowledge, data on sex differences in the antibody response in either RA or CIA are 
extremely limited. However, it has been shown that sex differences in B-cell signature in healthy subjects underlie 
disparities in incidence and course of some other antibody-mediated autoimmune diseases35. Most of immune 
related genes differentially expressed between sexes are significantly upregulated in B cells from females com-
pared to males35. Generally, females exhibit higher basal serum immunoglobulin levels and mount greater anti-
body responses to antigens than males36,37.
Considering all the aforementioned, the study was designed to examine: i) putative sex differences in the mag-
nitude of the total CII-specific IgG response in sera from DA rats affected by CIA, and its subclass profile, and ii) 
contribution of Th cell-dependent dLN GC reaction to IgG response in this model of RA.
Materials and Methods
Animals. The study included 22 male (250–280 g) and 22 female (180–210 g) four-month-old DA rats from 
the Immunology Research Center “Branislav Janković” animal facility (Belgrade, Serbia), authorized by The 
Ministry of Agriculture, Forestry and Water Economy of the Republic of Serbia. Animals (8 immunized rats/sex, 
in two independent experiments, and 6 non-immunized rats/sex included in one of these two experiments) were 
kept in polyethylene cages in an environment under standardized conditions regarding light, temperature, and 
humidity. Rats were fed on a standard food diet for rats and had access to tap water ad libitum. Animal care staff 
and veterinarian inspected the healthiness of rats on a daily basis. Design and methods applied in animal research 
were performed in keeping with the Directive 2010/63/EU of the European Parliament and of the Council on the 
protection of animals used for scientific purposes and the governmental regulations (The Law on Animal Welfare, 
“Official Gazette of Republic of Serbia”, no. 41/2009) and approved by The Ministry of Agriculture, Forestry and 
Water Economy of the Republic of Serbia (permit no. 323-07-01577/2016-05/14). The ARRIVE guidelines for 
reporting animal research were fully implemented in the study.
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Induction and clinical assessment of CIA. CIA was induced in rats anesthetized with a ketamine/xylazine 
cocktail by intradermal injection of 300 μg of bovine CII (Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) 
in incomplete Freund’s adjuvant (IFA) at the rat tail base as described10. From the 7th day post-immunization 
(d.p.i.) until the 21st d.p.i. rats were inspected for the development of arthritis daily. In brief, each paw was scored 
individually by the scoring system in which 1 point was given for inflamed metacarpophalangeal/metatarso-
phalangeal or interphalangeal joints of each toe, whereas 5 points were given to an inflamed wrist/ankle38. The 
maximum score for each paw was 15, providing the highest arthritis score of 60. The researchers (MD, NAR) 
assigned to evaluate the disease development were blinded to the experimental design.
Preparation of cells. On the 21st d.p.i. dLNs (popliteal) were isolated from rats deeply anesthetized with ket-
amine/xylazine cocktail, as previously described in detail10. For immunolabeling and cell cultures, single cell sus-
pensions were prepared by passing dLN tissue through 70 μm nylon cell strainer (BD Biosciences, Erembodegem, 
Belgium) in Petri dishes with ice-cold FACS buffer [phosphate buffered saline (PBS) supplemented with 2% fetal 
calf serum (FCS, Gibco, Grand Island, NY, USA) and 0.01% NaN3 (Sigma-Aldrich Chemie GmbH)] or culture 
medium [RPMI 1640 medium (Sigma-Aldrich Chemie GmbH) supplemented with 2 mM l-glutamine (Serva, 
Heidelberg, Germany), 1 mM sodium pyruvate (Serva), 100 units/ml penicillin (ICN, Costa Mesa, CA, USA), 
100 μg/ml streptomycin (ICN) and 10% FCS], respectively. Viable cells were counted in each suspension using 
improved Neubauer hemacytometer and trypan blue dye for the exclusion of non-viable cells.
Purification of dLN B cells. For measurement of T-bet mRNA levels, B cells (CD45RA+ cells) were sep-
arated from dLN mononuclear cell suspensions using magnetic-activated cell sorting (MACS). Briefly, dLN 
cells resuspended in degassed PBS containing 0.5% bovine serum albumin (BSA) and 2 mM ethylenediamine-
tetraacetic acid (MACS buffer) were incubated with rat CD45RA microbeads (clone OX-33; Miltenyi Biotec, 
Gladbach, Germany) for 15 min at 4 °C. Next, the cells were washed in MACS buffer and magnetically-labeled 
cell fraction was positively selected using LS type columns and QuadroMACS separator, as instructed by the man-
ufacturer (Miltenyi Biotec). Purity check showed CD45RA+ cell enrichment of >90% in resulting suspensions.
Immunolabeling and flow cytometry analysis (FCA). Immunostaining of lymph node cells and FCA 
were performed as previously described10. In brief, for surface immunolabeling, dLN cells were incubated with 
either fluorochrome-conjugated or unconjugated/biotin-conjugated monoclonal antibodies, followed by incuba-
tion with a second step reagent.
For intracellular cytokine staining, dLN cells were cultivated in culture medium with phorbol 12-myristate 
13-acetate, ionomycin and brefeldin A (4 h at 37 °C in 95% air–5% CO2), harvested and subjected to immunola-
beling. Intracellular staining for cytokine expression in in vitro restimulated cells and Foxp3 and Ki-67 expression 
in freshly isolated dLN cells was performed following surface immunostaining and overnight fixation/perme-
abilization with reagents from eBioscience in compliance with manufacturer’s instructions. Between the steps, 
cells were washed with permeabilization buffer (eBioscience). A list of monoclonal antibodies and second step 
reagents used in FCA is given in Supplementary Table S1.
Data were acquired on FACSCalibur flow cytometer (Becton Dickinson, Mountain View, CA, USA) and ana-
lysed by an examiner blinded for animal sex using FlowJo software version 7.8. (TreeStar Inc, Ashland, OR, USA) 
for the frequency of marker positive cells, and the changes in mean fluorescence intensity (MFI; median value of 
fluorescence intensity distribution) expressed as MFI ratio (MFI of antibody-labelled cells/MFI of negative con-
trols)39. Gating boundaries were set up using IgG isotype- and fluorochrome-matched and fluorescence minus 
one (FMO) controls.
CII recall test. Antigen-specific proliferation of B cells and cytokine production by T cells were examined in 
dLN cell cultures (3 × 105 cells per well in U-bottomed 96-well plate, Corning, NY, USA). The cells were cultured 
in the culture medium for 72 h at 37 °C, in 95% air–5% CO2 atmosphere, in the presence or in the absence of 5 μg/
ml of CII (Sigma-Aldrich Chemie GmbH).
ELISA. For measuring IL-17 (BioLegend, San Diego, CA, USA), IL-4 (Thermo Fisher Scientific, Waltham, 
MA, USA) and IFN-γ (R&D Systems, Minneapolis, MN, USA) levels in supernatants of dLN cell cultures, com-
mercial ELISA kits were used with the limits of detection at 8 pg/ml, 2 pg/ml, and less than 10 pg/ml, respectively. 
All procedures were performed according to the manufacturers’ instructions.
The serum levels of anti-CII IgG antibodies were detected by ELISA as described earlier9 with some mod-
ifications. Briefly, dilutions of sera (1:100–1:1600 for total IgG, and 1:100 for IgG1, IgG2a, IgG2b) were 
assayed in 96-well plates (MaxiSorp, Nunc) coated with 5 μg/ml of CII in 50 mM carbonate buffer pH 9.6 and 
blocked with 2% BSA. Biotin-conjugated secondary antibodies (1:1000; anti-rat IgG, IgG1, IgG2a and IgG2b 
antibodies, Biolegend Inc., San Diego, CA, USA), streptavidin peroxidase (1:3000) and extrAvidin-peroxidas
e/o-phenylendiamine system (Sigma, Steinheim, Germany) were used for the detection of specific antibodies. The 
absorbance was read at 492/620 nm (A492/620) on Multiscan Ascent (Labsystems, Helsinki, Finland).
RT-qPCR. RNA was isolated from dLN tissue or MACS-sorted CD45RA+ cell samples using TRIzol reagent 
obtained from Thermo Fisher Scientific (Waltham, MA, USA). RNA yield and purity were determined using 
Orion AquaMate 8000 spectrophotometer (Thermo Scientific, Waltham, MA, USA). cDNA was synthesized from 
total RNA using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA), 
following the manufacturer’s instructions. RT-qPCR reactions were set up in triplicate (25 μl final volume) using 
TaqMan Gene Expression Master Mix and premade TaqMan Gene Expression Assays, according to supplier’s pro-
tocols (Applied Biosystems). Both reverse transcription and RT-qPCR were performed using Applied Biosystems 
7500 Real-Time PCR System, as previously described in detail10. TaqMan Gene Expression Assays used in the 
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study: IL-2 (Il2; Rn00587673_m1), IL-21 (Il21; Rn01755623_m1), IL-7 (Il7; Rn00681900_m1), IL-27-subunit 
p28 (Il27; Rn01510484_m1), T-bet (Tbx21; Rn01461633_m1) and β-actin (Actb; Rn00667869_m1). SDS v1.4.0. 
software (Applied Biosystems) was used for data analysis. Relative target mRNA expression levels normalized to 
the internal standard (β-actin) were calculated using the comparative threshold cycle (Ct) method and presented 
as 2−dCt. dCt values were obtained by subtracting Ct values for the internal control gene from Ct values for target 
genes.
Statistical analysis. Data were analysed using GraphPad Prism 6 software (GraphPad Software, Inc., La 
Jolla, CA, USA). Statistically significant differences between the groups were assessed by two-tailed Student’s t-test 
unless otherwise indicated. Data are presented as mean ± SEM. Values of p < 0.05 were considered significant.
Results
Greater B cell response to CII in dLNs from female compared with male CIA rats. As previously 
shown9,10, female DA rats develop more severe CIA (Fig. 1a). To test the contribution of sex differences in B-cell 
antibody response to this dimorphism, B cells recovered from dLNs on the 21st d.p.i. were examined for num-
ber and phenotypic properties. Irrespective of sex, more mononuclear cells were recovered from dLNs from 
CII-immunized rats compared with sex-matched controls, but this increase was more prominent (p < 0.001) in 
female rats (Fig. 1b). Consequently, differently from popliteal LNs from non-immunized rats exhibiting a similar 
Figure 1. Sex difference in the proliferative capacity of B cells from CIA rats. (a) Line graph indicates daily 
arthritis score in male and female rats until the peak of the disease (on the 21st day post-immunization). 
Clinical signs were graded on an arbitrary scale as described in Materials and Methods. (b) Cells were obtained 
from lymph nodes draining inflamed joints and nearby tissues (dLNs) recovered at the peak of the clinical 
severity of CIA. Scatter plots show the absolute number of dLN lymphocytes and the absolute number of B 
cells (CD45RA+) from CII-immunized and non-immunized male and female rats. Two-way ANOVA (sex × 
immunization) showed: a significant interaction between factors (F(1,24) = 64.91, p < 0.001) and a significant 
main effects of sex (F(1,24) = 63.98, p < 0.001) and immunization (F(1,24) = 545.7, p < 0.001) for absolute 
number of dLN lymphocytes; and a significant interaction between factors (F(1,24) = 11.26, p < 0.01) and a 
significant main effects of sex (F(1,24) = 10.34, p < 0.01) and immunization (F(1,24) = 183.9, p < 0.001) for absolute 
number of B cells. Multiplicity corrected p values are reported for Bonferroni tests. (c) Representative flow 
cytometry dot plots show Ki-67 staining of CD45RA+ cells from dLNs of male and female rats. The number 
indicates the percentage in the region. A scatter plot shows the frequency of proliferating Ki-67+ cells among 
CD45RA+ cells. (d) Scatter plot shows the percentage of increase in the frequency of proliferating Ki-67+ 
cells among CD45RA+ cells from male and female CII-supplemented dLN cell cultures over CII-free dLN cell 
cultures from sex-matched rats (CII recall test). Data are presented as means ± SEM. Horizontal lines within 
scatter plots indicate mean values. n = 6-8 rats per group. *p < 0.05, **p < 0.01, ***p < 0.001.
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number of mononuclear cells, more (p < 0.001) mononuclear cells were retrieved from dLNs of CII-immunized 
female rats compared with their male counterparts (Fig. 1b). Additionally, irrespective of sex, more (p < 0.001) 
CD45RA+ cells (B cells) were recovered from dLNs of CII-immunized rats when compared with sex-matched 
non-immunized rats. However, this effect of immunization was more prominent in females (Fig. 1b). Given that 
their number was comparable between female and male non-immunized rats, more (p < 0.01) CD45RA+ cells 
were retrieved from dLNs of CII-immunized female rats compared with their male counterparts (Fig. 1b).
Next, the frequency of Ki-67+ activated/proliferating cells among B cells was examined. In accordance with 
the previous findings, their frequency was higher (p < 0.01) in female rats compared with their male counterparts 
(Fig. 1c). Given that these findings only indicated that after immunization with CII there were more activated/
proliferating cells among female than male rat dLN B cells, but did not provide information about their antigen 
specificity, dLN B cells were restimulated with CII in vitro and the percentage of increase in the frequency of 
Ki-67+ cells among restimulated B cells over that among non-stimulated B cells (in control cultures without CII) 
was examined. As expected, upon stimulation with CII greater (p < 0.05) increase in the frequency of Ki-67+ 
cells was registered among dLN B cells from female rats compared with male ones (Fig. 1d).
Next, to assess whether the sex difference in in vitro activation/proliferation of CII-specific B cells correlated 
with the sex differences in the frequency of B cells involved in GC reaction (GC B cells), freshly isolated dLN 
B cells were examined for surface IgM expression. Namely, differently from IgM+ naïve and memory B cells40, 
class-switched IgG antibody-secreting GC B cells are suggested to express IgMlow/− phenotype41. Indeed, the fre-
quency of IgMlow/− cells among dLN B cells, and their number, were greater (p < 0.05) in female than in male rats 
(Fig. 2a). Next, considering that the transcription factor IRF4 is indispensable not only for GC formation but also 
for terminal differentiation of B cells to antibody-secreting plasma cells42, its expression in dLN B cells was exam-
ined. In accordance with the higher frequency of IgMlow/− cells among dLN B cells from female rats, the frequency 
of IRF4+ cells among dLN B cells (p < 0.001), and IRF4 expression level (as indicated by MFI ratio) in these cells 
(p < 0.01) were greater in female than in male rats (Fig. 2b).
Figure 2. Sex differences in the generation of germinal centre (GC) B cells and IRF4 expression in B cells 
from CIA rats. Cells were obtained from lymph nodes draining inflamed joints and nearby tissues (dLNs) 
recovered at the peak of the clinical severity of CIA. (a) Representative flow cytometry histogram overlays 
display IgM expression on CD45RA+ cells from dLNs of male and female CII-immunized (CII) and non-
immunized (NIM) rats. The number indicates the percentage in the region. Scatter plots show the frequency 
of IgMlow/− cells among CD45RA+ cells (GC B cells) and the number of GC B cells from dLNs of male and 
female rats. (b) Representative flow cytometry histogram overlay displays IRF4 expression on CD45RA+ cells 
from dLNs of male and female rats. The number indicates the percentage in the region. Scatter plots show 
the percentage of IRF4+ cells among CD45RA+ cells and IRF4 mean fluorescence intensity (MFI) ratio of 
IRF4+ CD45RA+ cells from dLNs of male and female rats. Data are presented as means ± SEM. Horizontal 
lines within scatter plots indicate mean values. n = 8 rats per group. *p < 0.05, **p < 0.01, ***p < 0.001.
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B cells from dLNs of female CIA rats “enjoy” greater CD4+ T-cell help. Given that GC formation 
and the production of class-switched antibodies is reliant on the activation of antigen-specific B cells by CD4+ 
T cells capable of recognizing epitopes of the same antigenic complex, and that CD40:CD40L (CD154) contact 
is critical in this interaction43, the expression of CD40 and CD40L was investigated on CD45RA+ and CD4+ 
cells recovered from dLNs, respectively. The frequency of CD40+ cells among B cells (Fig. 3a), as well as that 
of CD40L+ cells among CD4+ cells (Fig. 3b), were higher (p < 0.01) in female than in male rats. Besides, the 
surface density of CD40 on B cells (Fig. 3a; Supplementary Fig. S1), as that of CD40L on CD4+ cells (Fig. 3b, 
Supplementary Fig. S1), judging by MFI in the corresponding channels, was greater (p < 0.05) in female than in 
male rats.
Considering that Tfh cells specialized in providing help to B cells are essential for GC formation, affinity matu-
ration, and the development of memory B cells27, whereas Tfr cells are critical for controlling Tfh cell:B cell inter-
action29,30, dLN cells were also examined for their frequency. To identify these cells, conventional Foxp3-CD4+ 
cells and Foxp3+ CD4+ cells encompassing predominantly regulatory T cells44 (Supplementary Fig. S2) were 
examined for CXCR5 expression31. The frequency of CXCR5+ cells among Foxp3- CD4+ cells (presumably 
Tfh cells) (p < 0.01) and their number (p < 0.001) were greater in female than in male rat dLNs (Fig. 4a). On the 
other hand, the frequency of CXCR5+ cells among Foxp3+ CD4+ cells (mainly Tfr cells) was lower (p < 0.01) 
in female than in male rat dLNs (Fig. 4a). The number of Foxp3+ CD4+ cells was greater (p < 0.05) in females 
(Supplementary Fig. S2), while the number of Tfr cells was comparable between sexes (Fig. 4a), suggesting their 
less efficient generation in females. Consequently, Tfr/Tfh cell ratio was shifted (p < 0.001) towards Tfh cells in 
female compared with male rats (Fig. 4b). The lower percentage of Tfr cells in female than in male rats is sug-
gestive of their impaired differentiation from the precursor cells (Supplementary Fig. S2). It is noteworthy that 
in non-immunized rats, there were no significant sex differences in the frequency of either Tfh (1.24 ± 0.09% of 
Foxp3-CD4+ cells in males vs 1.11 ± 0.12% in females) or Tfr (3.2 ± 0.28% of Foxp3+ CD4+ cells in males vs 
Figure 3. Sex differences in the expression of co-stimulatory molecules CD40 and CD40L (CD154) on 
lymphocytes from CIA rats. Cells were obtained from lymph nodes draining inflamed joints and nearby 
tissues (dLNs) recovered at the peak of the clinical severity of CIA. (a) Representative flow cytometry dot 
plots show CD40 staining of CD45RA+ cells from dLNs of male and female rats. The number indicates the 
percentage in the region. Scatter plots show the frequency of CD40+ cells among CD45RA+ cells and CD40 
mean fluorescence intensity (MFI) ratio of CD40+ CD45RA+ cells from dLNs of male and female rats. (b) 
Representative flow cytometry dot plots show CD40L (CD154) staining of CD4+ cells from dLNs of male 
and female rats. The number indicates the percentage in the region. Scatter plots show the frequency of 
CD40L + cells among CD4+ cells and CD40L mean fluorescence intensity (MFI) ratio of CD40L+ CD4+ cells 
from dLNs of male and female rats. Data are presented as means ± SEM. Horizontal lines within scatter plots 
indicate mean values. n = 8 rats per group. *p < 0.05, **p < 0.01.
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3.0 ± 0.39% in females) cells in LNs. Thus, it may be assumed that the sex differences in the frequency and the 
number of Tfh and Tfr cells appeared in the response to immunization.
Given that Tfr cells, apart from Tfh-cell activity, control GC B-cell activity31,32, Tfr/B cell ratio in dLNs was also 
calculated. This ratio was shifted (p < 0.01) towards GC B cells in female rats compared with their male counter-
parts (Supplementary Fig. S3).
Considering that the differentiation of Tfh cells depends on the balance of cytokines exerting the opposing 
action on this process45, the expression levels of mRNAs for cytokines promoting (IL-21 and IL-27) and inhibiting 
Figure 4. Sex differences in the generation of Tfh cells and Tfr cells in CIA rats. Cells were obtained from 
lymph nodes draining inflamed joints and nearby tissues (dLNs) recovered at the peak of the clinical severity 
of CIA. (a) Representative flow cytometry dot plots show Foxp3 staining of CD4+ cells and CXCR5 expression 
on Foxp3+ CD4+ and Foxp3- CD4+ cells from dLNs of male and female rats. The number indicates the 
percentage in the region. Scatter plots show the frequency of CXCR5+ cells among Foxp3- CD4+ and Foxp3+ 
CD4+ cells and the absolute number of Tfh and Tfr cells from dLNs of male and female rats. (b) A scatter plot 
shows Tfr/Tfh cell ratio in dLNs of male and female rats. Data are presented as means ± SEM. Horizontal lines 
within scatter plots indicate mean values. n = 8 rats per group. **p < 0.01, ***p < 0.001.
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(IL-2 and IL-7) their differentiation were analysed. The expression levels of mRNAs for IL-21 and IL-27 were 
greater (p < 0.05), whereas that of IL-2 mRNA was less (p < 0.05) in female than in male rat dLNs (Fig. 5). On the 
other hand, a similar amount of mRNA encoding IL-7 was found in female and male dLNs (Fig. 5).
Female CIA-affected rats mount higher total serum level of CII-specific antibodies and exhibit 
the shift in IgG2a(b)/IgG1 ratio towards an IgG2a(b) response. To examine the significance of GC 
reaction for the sex differences in the production of autoantibodies in response to immunization with CII, the 
total serum level of CII-specific IgG and its subclasses were examined. The serum level of anti-CII IgG antibody 
was greater (p < 0.05) in female than in male rats (Fig. 6a). Considering sex differences in the IgG autoantibody 
subclass profile in some other autoimmune diseases46, the subclass profile of IgG specific to CII was additionally 
assessed. The serum level of CII-specific IgG1 antibody47,48 was lower (p < 0.001) in female rats than in their 
male counterparts (Fig. 6b). On the contrary, the serum level of CII-specific IgG2a antibody shown to be highly 
pathogenic47,48 was higher (p < 0.01) in female rats than in their male counterparts (Fig. 6b). There was no sex 
difference in the serum level of CII-specific IgG2b antibody (Fig. 6b). Consequently, compared with male rats, in 
female rats IgG2a/IgG1 and IgG2b/IgG1 antibody ratios were shifted (p < 0.001) towards IgG2a and IgG2b anti-
body, respectively (Fig. 6c). Given that T-bet promotes class switching to IgG2a49, the expression level of mRNA 
for T-bet was investigated in B cells recovered from dLNs of CII-immunized rats of both sexes, and in B cells 
isolated from the popliteal LNs from non-immunized control rats. There was no sex difference in T-bet mRNA 
expression in B cells from non-immunized rats. However, following immunization with CII greater increase 
(p < 0.001) in T-bet mRNA expression was observed in female than in male rat dLN B cells (Fig. 6d).
Sex differences in CII-specific IgG subclass profile correlate with those in T-cell cytokine pro-
file. Considering that although IFN-γ and IL-4 predominantly regulate IgG class switching in rats22,23, IL-17 
could also contribute to its shaping, as IL-17 deficient mice exhibit impaired production of collagen-specific 
IgG2a antibodies24, dLNs were examined for the frequency of IFN-γ-, IL-4- and IL-17-producing T cells. The 
frequencies of T cells producing IFN-γ and IL-17, the cytokines favouring production of IgG2 antibody22,24, were 
higher (p < 0.05) in female than in male rat dLNs, whereas there was no sex difference in the frequency of IL-4+ 
T cells (Supplementary Fig. S4). Additionally, the concentrations of IFN-γ, IL-17, and IL-4 were examined in 
CII-stimulated dLN cell cultures. There were no sex differences in the production of these cytokines in control 
(medium only) cultures (Fig. 7a). Their concentrations increased in CII-stimulated dLN cell cultures from rats 
of both sexes when compared with sex-matched control cultures (Fig. 7a). The concentrations of IFN-γ and 
IL-17 were greater (p < 0.05) in female than in male rat CII-stimulated dLN cell cultures (Fig. 7a). On the other 
hand, IL-4 concentration was comparable in CII-stimulated dLN cell cultures from female and male rats (Fig. 7a). 
Considering that IFN-γ/IL-4 production level ratio rather than the production level of any of these two cytokines 
is important in regulating IgG class switching50, IFN-γ/IL-4 production ratio was calculated. Indeed, consistent 
with IgG2a/IgG1 antibody ratio, this ratio was shifted (p < 0.05) towards IFN-γ in female rat CII-stimulated dLN 
cell cultures compared with corresponding cultures from male rats (Fig. 7b).
Discussion
The present study extended our earlier findings on sexual dimorphism in susceptibility to CIA9,10 recapitulating 
female predominance observed in RA by showing that female rats mount quantitatively greater and qualitatively 
different CII-specific IgG response compared with their male counterparts. This was associated with the more 
efficient generation of Tfh cells and most likely CD40L/CD40-mediated interactions between Th cells and B cells, 
and the shift in Th1/Th2 signature cytokine production ratio towards the former in females compared with males. 
The greater total serum CII-specific IgG response in female rats compared with male counterparts was consistent 
with data indicating that, generally, females mount a stronger IgG response than males36,37. Additionally, this 
Figure 5. Sex differences in the expression of cytokines regulating the generation of Tfh cells and Tfr cells in 
CIA rats. Lymph nodes draining inflamed joints and nearby tissues (dLNs) were recovered at the peak of the 
clinical severity of CIA. Bar graphs show expression of mRNAs for IL-21, IL-27/p28, IL-2 and IL-7 in dLN tissue 
of male and female rats, as determined by RT-qPCR. Results are represented as 2−dCt relative to β-actin. Data are 
presented as means ± SEM. n = 8 rats per group. *p < 0.05.
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was in accordance with data indicating that greater severity of rheumatoid arthritis in women than man could 
be ascribed to the stronger humoral immune response in women51. However, the analysis of the influence of sex 
on the antibody of distinct specificities showed it may vary depending on antibody specificity52,53. Furthermore, 
differently from rat CIA models and the human disease, in several mouse CIA models sex differences in serum 
levels of autoantibodies have not been found54,55, suggesting that this dimorphism may be not only antigen but 
also species/strain specific. The stronger total IgG response in female compared with male CIA-affected rats cor-
related with the greater number of GC B cells in dLNs from female rats. Of note, this reflected a more prominent 
increase in their number in the response to immunization with CII in dLNs from female compared with male 
rats. This correlated with the greater frequency of activated/proliferating Ki-67+ cells among dLN B cells from 
female rats compared with male rats. To the best of our knowledge, there is no data on sex differences in intrinsic 
B-cell activation/proliferation capacity. In a model of RA induced by transfer of hematopoietic stem cells from RA 
patients into immunodeficient mice, more B cells were retrieved from peripheral blood of female recipients com-
pared with male recipients, indicating that sex-specific extrinsic microenvironmental factors rather than B-cell 
intrinsic factors contributed to the sex differences in the B-cell number56. Additionally, it was shown that estrogen 
increases the number of autoreactive B cells in the naive repertoire by protecting/increasing the survival of the 
immature B cells that would normally be deleted57. The greater proliferation of B cells in CII-stimulated dLN cell 
cultures from female compared with male rats is fully consistent with this finding. Furthermore, it was found that 
estrogen acting directly on B cells upregulates not only genes involved in B-cell survival but also in their activa-
tion57. These findings have been associated with an increased propensity towards the development of autoimmune 
diseases in female compared with male rats57. In the same vein, androgens were shown to have the opposite effect 
on B-cell survival providing an additional explanation for sex differences in susceptibility to antibody-mediated 
autoimmune diseases58. Consistently, we found a lower frequency of Annexin V+ cells among B cells from female 
rats compared with their male counterparts (Supplementary Fig. S5).
On the other hand, considering that Tfh cells provide critical signals to antigen-primed B cells in GCs to 
undergo proliferation during an immune response27, the greater activation/proliferation of B cells from female 
rats could be associated not only with the greater number of CII-specific B cells, but also with the more Tfh 
Figure 6. Sex differences in serum levels of CII-specific IgG antibodies and T-bet mRNA expression in B 
cells in CIA rats. Serum was obtained at the peak of the clinical severity of CIA. (a) Line graph indicates the 
serum levels of anti-CII IgG in male and female rats, as shown by mean optical densities (OD) at 492 nm in 
ELISA anti-IgG reaction performed with increasing dilutions of the sera. (b) Scatter plots represent serum 
(1:100 dilution) levels (OD at 492 nm) of IgG1, IgG2a and IgG2b antibodies. (c) Scatter plots represent IgG2a/
IgG1 and IgG2b/IgG1 antibody level ratios in male and female rats. (d) Scatter plot shows mRNA expression 
of T-bet in B cells purified from lymph nodes draining inflamed joints and nearby tissues (dLNs) from CII-
immunized (at the peak of clinical severity of CIA) and from non-immunized male and female rats. Two-way 
ANOVA (sex x immunization) showed: a significant interaction between factors (F(1,24) = 18.41, p < 0.001) 
and a significant main effects of sex (F(1,24) = 20.88, p < 0.001) and immunization (F(1,24) = 156.2, p < 0.001). 
Multiplicity corrected p values are reported for Bonferroni tests. Data are presented as means ± SEM. 
Horizontal lines within scatter plots indicate mean values. n = 6–8 rats per group. **p < 0.01, ***p < 0.001.
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cells in female compared with male rat dLNs. This may be linked with estrogen-sensitive PPARγ/dependent 
differentiation of Tfh cells59. A more prominent increase in the number of Tfh cells in female rat dLNs following 
immunization with CII leading to sex bias in their number in immunized rats (greater number in females) was 
consistent with data indicating that Th cells from adult women and female mice have greater proliferative capac-
ity than those from age-matched men and male mice, respectively60,61. Additionally, we have recently shown the 
greater activation/proliferation of Th cells from dLNs of female CII-immunized DA rats compared with their 
male counterparts10. Our findings also revealed the enhanced expression of IL-21 and IL-27, the cytokines sup-
porting Tfh-cell differentiation45, in female compared with male rat dLN cells. Given that IL-12p/35 stimulates 
IL-21 expression45, the upregulated expression of IL-21 in dLN cells from females compared with males was 
consistent with the greater IL-12p/35 expression in their dLNs10. It should be emphasized that IL-21, as IL-2762, 
supports not only Tfh-cell differentiation and thereby GC B-cell formation and function, but also directly acts 
on B cells supporting their growth, survival, and antibody secretion33. It is noteworthy that in RA patients the 
increased serum IL-21 levels correlate with the disease activity, frequency of Tfh-like cells and anti-citrullinated 
peptide antibody level33. To the greater Tfh-cell generation in female than in male rats' dLNs could also contrib-
ute the lower expression of IL-2, the cytokine involved in the negative regulation of Tfh-cell differentiation45, in 
female rat dLN cells. In favour of our findings are data indicating that estrogen-stimulated CD40L expression on 
activated CD4+ T cells contributes to a greater incidence of several antibody-mediated autoimmune diseases in 
women63,64. To point out to the significance of this finding are data indicating that: i) the increased expression of 
CD40L on peripheral blood CD4+ T cells has been approved as a marker of disease activity in RA65 and ii) the 
CD40L/CD40 pathway has recently been recognized as a potential target for innovative therapy in several auto-
immune diseases, including RA42. Additionally, greater expression of CD40 was found in B cells from women 
compared with men66. This dichotomy was associated with the greater circulating 17β-estradiol level in women 
and suggested to be critical for sex-based differences in autoimmune disease incidence67.
Given that Tfh/Tfr cell ratio rather than solely the number of Tfh cells determines the magnitude of antibody 
response31,43, it should be emphasized that Tfr/Tfh cell ratio was shifted towards Tfh cells in female compared with 
male rat dLNs. To corroborate this finding, compared with male mice in female mice mounting stronger anti-
body response to influenza vaccine antigens the shift in Tfr/Tfh cell ratio to the Tfh cell side in secondary lymph 
Figure 7. Sex differences in the capacity of T cells to produce Th1, Th2 and Th17 signature cytokines in CII-
stimulated cell cultures. Cultured cells were obtained from lymph nodes draining inflamed joints and nearby 
tissues (dLNs) recovered at the peak of clinical severity of CIA. (a) Scatter plots indicate the concentration of 
IFN-γ, IL-4 and IL-17 in 72-hour dLN cell cultures from male and female rats without CII (medium) or with 
CII (CII). Two-way ANOVA (sex x culturing condition) showed: a significant interaction between factors 
(F(1,28) = 13.04, p < 0.01) and a significant main effects of sex (F(1,28) = 27.84, p < 0.001) and culturing conditions 
(F(1,28) = 59.91, p < 0.001) for IFN-γ; a significant main effect of culturing conditions (F(1,28) = 49.34, p < 0.001) 
for IL-4; and a significant main effects of sex (F(1,28) = 9.06, p < 0.01) and culturing conditions (F(1,28) = 80.86, 
p < 0.001) for IL-17. (b) Scatter plot shows IFN-γ/IL-4 concentration ratio in 72-hour dLN cell cultures with CII 
from male and female rats. Data are presented as means ± SEM. Horizontal lines within scatter plots indicate 
mean values. n = 8 rats per group. *p < 0.05, **p < 0.01, ***p < 0.001.
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organs was also found50. Additionally, lack of Tfr cells or the shift Tfr/Tfh cell ratio towards Tfh cells is shown to 
increase the risk of autoimmunity and autoantibody68. Considering the critical role of a CD40L/CD40-mediated 
interactions in the establishment of an effective thymus-dependent humoral immune response and pathogenesis 
of experimental autoimmune diseases69, including CIA70, the greater antibody response in female compared with 
male CIA rats could be partly ascribed to the greater density of CD40L and CD40 on CD4+ T cells and B cells, 
respectively.
Further, given that Tfr cells shape the GC response and balance tolerance not only through interactions with 
Tfh (by modifying their number and function, and thereby GC B-cell response), but also directly interacting with 
B cells71, the lower Tfr/GC B-cell ratio in female compared with male rat dLNs could also contribute to the greater 
CII-specific IgG antibody response in females, and consequently the greater severity of the disease.
Finally, the greater magnitude of CII-specific IgG response in females compared with males could be 
linked with the greater expression of IRF4 in B cells, as its enhanced expression upregulates the expression of 
B lymphocyte-induced maturation protein 1 (Blimp1) in B cells, and consequently their differentiation into 
antibody-secreting plasma cells42. Thus, the higher frequency of IRF4+ cell in female rat B cells indicates more 
plasma cells in their dLNs42. To additionally support this notion it should be added that IRF4 was identified as 
a particularly important protein involved in the RA-mediated production of IgG in stimulated B cells72. Sex 
difference in the expression of IRF4 could also be linked with findings indicating that estrogen upregulates IRF4 
expression in dendritic cells73.
Moreover, it should be emphasized that sex differences were also found in qualitative characteristics of IgG 
response, as the serum CII-specific IgG2a(b)/IgG1 ratio was shifted towards an IgG2a(b) response in females 
compared with males, reflecting reduced levels of IgG1 accompanied by increased and unaltered levels of IgG2a 
and IgG2b, respectively. The higher serum level of IgG2a could be related to the greater expression of T-bet 
in B cells from female rats affected by CIA compared with their male counterparts, as it was shown T-bet has 
a crucial role in the switching antibody response toward IgG2a74. In favour of these findings was the sexual 
Figure 8. Schematic presentation of mechanisms underlying sex differences in germinal centre (GC) reaction 
leading to the greater magnitude and more pathogenic profile of IgG response in female compared with male 
rats immunized with collagen type II (CII). The greater magnitude of the serum CII-specific IgG response in 
female compared with male rats could be associated with the greater number of GC B cells in lymph nodes 
draining inflamed joints and adjacent tissue (dLNs) from females reflecting most likely the greater number of 
CII-specific B cells, their augmented proliferation, and increased IRF4 expression. This was consistent with the 
greater proliferation of Th cells and a more efficient generation of Tfh cells in female dLNs expressing a more 
favourable cytokine milieu [mirrored in greater and less expression of cytokines supporting (IL-21 and IL-27) 
and inhibiting (IL-2) Tfh-cell differentiation, respectively] followed by comparable number of Tfr cells exerting 
suppressive action on B cells either directly or indirectly acting on Tfh cells. Hence, in female rats, Tfr/Tfh 
and Tfr/B-cell ratios were shifted towards Tfh and GC B cells, respectively. Additionally, to the greater serum 
total CII-specific IgG response in female compared with male rats contributed a more efficient T-cell to B-cell 
communication trough CD40L/CD40 interactions (judging by their surface densities), and increased IL-21/
IL-27 expression in dLN cells. The shift in the serum CII-specific IgG2a/IgG1 antibody ratio to the side of IgG2a 
antibody in female compared with male rats reflected the shifted INF-γ/IL-4 production ratio toward INF-γ, 
and possibly sex difference in the total Tfr-cell suppressive capacity in female rats. Red arrows (inhibition); 
green arrows (stimulation).
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dimorphism in serum IgG subclass profile in response to stimulation with some other (auto)antigens in humans 
and mice46,50. The shift in IgG2a/IgG1 ratio in females compared with males was in accordance with the higher 
frequency of INF-γ-producing T cells in dLNs from female compared with male rats, and the higher INF-γ 
levels in CII-stimulated female rat dLN cell cultures22 leading to the shift in INF-γ/IL-4 production ratio to the 
side of INF-γ. This shift in INF-γ/IL-4 production ratio in female CIA-affected rats could be ascribed to the 
greater expression of T-bet in their B cells74. To corroborate this finding are data from some previous studies 
indicating disease-associated sexual dimorphism in the production levels of Th1/Th2 signature cytokines, i.e. 
so-called “cytokine level network profile”75. To additionally corroborate the higher serum level of IgG2a anti-
body was the higher frequency of IL-17+ T cells in dLNs from female compared with male rats and IL-17 level 
in CII-stimulated dLN cell cultures from female rats24, as well as enhanced expression of IL-27 in female rat 
dLNs76. On the other hand, despite the lower serum level of IgG1 in females, the frequency of T cells producing 
IL-4, the cytokine associated with regulation of IgG1 antibody production23, in dLNs was comparable between 
sexes, whereas IL-4 levels in CII-stimulated dLN cell cultures did not significantly differ between female and male 
rats. This was in line with previous data indicating that the ratio between production levels of cytokines driving 
IgG subclass switching rather than their absolute concentrations determines IgG subclass profile50. Additionally, 
given that Tfr cells acting on GC B cells either directly or indirectly, via Tfh-mediated mechanism, influence IgG 
switching77, it may be speculated that sex differences in Tfr-cell regulatory action also contributed to the sex 
bias in IgG subclass profile. The relationship between the serum levels of different CII-specific IgG subclasses 
and clinical CIA is not well-defined. Effective therapies of CIA in rats have been associated with the decline in 
IgG2a48,78 and IgG2b47,48 antibody levels and unaltered47,48,79/increased47 levels of IgG1, suggesting the relevance 
of IgG2/IgG1 level ratio as a parameter of the severity of the disease. This could be ascribed to differences in func-
tional properties of distinct IgG subclasses (isotypes)80. In this context, it should be pointed out that CII-specific 
IgG2a antibody, as the most potent activator of Fc receptor-bearing macrophages among IgG antibodies80, is 
suggested to have a key pathogenic role in rats47,48 and mice81,82. However, it should be also mentioned that there 
are data indicating that pathogenic potential of district IgG subclasses did not substantially differ in some mouse 
CIA models54,55. This inconsistency could be reconciled by data indicating that pathogenic effects of IgG anti-
body depend not only on the antibody class/subclass profile, but also on their titres and the target organ reflect-
ing the abundance of the target FcγR bearing inflammatory cells21. Thus, considering the greater infiltration of 
CIA-inflicted paws with inflammatory cells9, particularly ED1+ macrophages (data not shown), it may be spec-
ulated that the greater generation of IgG2a antibody in female rats compared with their male counterparts was of 
pathogenic significance.
In conclusion, the current study showed the greater magnitude of serum CII-specific IgG response with the 
prevalence of IgG2a antibodies in females exhibiting greater susceptibility to CIA, and pointed out to the putative 
role of T-cell mechanisms in these dimorphisms. Consequently, it suggested the new T-cell targets for further 
translational pharmacology research (Fig. 8) aimed to identify sex-specific treatments in RA to improve thera-
peutic success rates.
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